Yixiang
Yixiang Lu, Nantong CN
Patent application number | Description | Published |
---|---|---|
20120071542 | Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas - This invention relates to the application of the highly conserved sequences of viral genome, especially from a highly conserved domain of enteroviral genome as templates to design target small ligand RNAs (sliRNAs). The resulting sliRNAs are therapeutically active ingredients in the treatment of the related diseases caused by pathological angiogenesis. | 03-22-2012 |
20130210894 | APPLICATION OF HIGHLY CONSERVED DOMAIN SEQUENCES FROM VIRAL GENOME AS TEMPLATE TO DESIGN THERAPEUTIC SLIRNAS - This invention relates to the application of the highly conserved sequences of viral genome, especially from a highly conserved domain of enteroviral genome as templates to design target small ligand RNAs (sliRNAs). The resulting sliRNAs are therapeutically active ingredients in the treatment of the related diseases caused by pathological angiogenesis. | 08-15-2013 |
Yixiang Wang, Mobile, AL US
Patent application number | Description | Published |
---|---|---|
20100183542 | Synergism Between Activated Immune Cells and Conventional Cancer Therapies - The present invention relates to a composition, method and kit for treating cancer. The treatment comprises administering a pre-sensitizing agent to a tumor or subject, and administering a cancer therapy to the tumor cells or subject. The pre-sensitizing agent increases or induces the apoptosis of the tumor cells, as compared to the rate of apoptosis of tumor cells that have not been pre-sensitized prior to receiving the cancer therapy. In another aspect, the invention relates to a kit comprising a pre-sensitizing agent and a cancer therapy. | 07-22-2010 |
Yixiang Wang, Shatin CN
Patent application number | Description | Published |
---|---|---|
20110217379 | MAGNETIC NANOMATERIALS AND METHODS FOR CHEMOEMBOLISATION - There are disclosed magnetic nanoparticles and embolisation compositions comprising the nanoparticles. There are also disclosed methods to make the nanoparticles and embolisation compositions and methods to deliver therapeutic agents to a subject. | 09-08-2011 |
Yixiang Zhang, Brighton, MA US
Patent application number | Description | Published |
---|---|---|
20120277231 | QUINOLINYLOXYPHENYLSULFONAMIDES - The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases. | 11-01-2012 |